<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335646">
  <stage>Registered</stage>
  <submitdate>22/06/2010</submitdate>
  <approvaldate>23/06/2010</approvaldate>
  <actrnumber>ACTRN12610000519055</actrnumber>
  <trial_identification>
    <studytitle>The effect of iodine supplementation on cognition and well-being in mildly deficient young adults</studytitle>
    <scientifictitle>A randomised controlled trial to determine the effect of iodine supplementation on cognition and well-being in mildly deficient young adults</scientifictitle>
    <utrn>U1111-1115-5764</utrn>
    <trialacronym>THINK2</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>cognition, well-being and iodine status</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>150 micrograms of iodine/day orally for 32 weeks</interventions>
    <comparator>placebo (eg sugar pill identical to intervention exposure)/day orally for 36 weeks</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cognition as measured by subtests of the Weschler Adult Intelligence Scales.</outcome>
      <timepoint>Baseline and 32 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Well-being as measured by Short-Form 36 (SF-36).</outcome>
      <timepoint>Baseline and 32 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Iodine status as measured by urinary iodine concentration, and thyroglobulin</outcome>
      <timepoint>Baseline and 32 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>18-30 years
healthy
free of thyroid disease
not pregnant
not taking iodine containing supplements
mildly iodine deficient</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>30</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Eats more than 2 servings of commercial bread products a day.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subject randomly allocated to placebo or treatment. Treatment and placebo tablets are identical and given letter code by third party not involved in research.</concealment>
    <sequence>Block randomisation using the RAND function in Excel.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>5/07/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>300</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Otago</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Dept Human Nutrition, University of Otago</primarysponsorname>
    <primarysponsoraddress>PO Box 56, Dunedin 9054</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Dept Human Nutrition, University of Otago</fundingname>
      <fundingaddress>PO Box 56, Dunedin 9054</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Maurice and Phyllis Paykel Trust</fundingname>
      <fundingaddress>PO Box 37760 
Parnell, Auckland 1151</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Charities/Societies/Foundations</sponsortype>
      <sponsorname>Maurice and Phyllis Paykel Trust</sponsorname>
      <sponsoraddress>PO Box 37760 
Parnell, Auckland 1151</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A recent study has found that additional iodine in iodine deficient children improved iodine status and cognition. The brain continues to develop until 40 years of age. The aim of this study is to determine the effect of additional iodine on cognition and well being in mildly iodine deficient young adults.</summary>
    <trialwebsite>None</trialwebsite>
    <publication>Gordon RC et al. Iodine supplementation improves cognition in mildly iodine-deficient children. Am J Clin Nutr 2009;90:1264-71</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Otago Ethics Committee</ethicname>
      <ethicaddress>PO Box 56
Dunedin 9054</ethicaddress>
      <ethicapprovaldate>1/06/2010</ethicapprovaldate>
      <hrec>1/10/0026</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Sheila Skeaff</name>
      <address>Dept Human Nutrition
University of Otago
PO Box 56
Dunedin, 9054</address>
      <phone>+643-479-7944</phone>
      <fax>+643-479-7958</fax>
      <email>sheila.skeaff@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Sheila Skeaff</name>
      <address>Dept Human Nutrition
University of Otago
PO Box 56
Dunedin, 9054</address>
      <phone>+643-479-7944</phone>
      <fax>+643-479-7958</fax>
      <email>sheila.skeaff@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Sheila Skeaff</name>
      <address>Dept Human Nutrition
University of Otago
PO Box 56
Dunedin, 9054</address>
      <phone>+643-479-7944</phone>
      <fax>+643-479-7958</fax>
      <email>sheila.skeaff@otago.ac.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>